Poster # Poster Title and Authors
1 A CASE OF CD19-DIRECTED CAR-T CELL THERAPY IN A PATIENT WITH REFRACTORY ANTI-JO1-ANTISYNTHETASE-SYNDROME
Johanna Richter, Martin Krusche, Isabell Haase, Boris Fehse, Mathias Schäfersküpper, Franziska Elisabeth Marquard, Kristin Rathje, Nico Gagelmann, Anita Badbaran, Maroly Bohorquez Manjarres, Marie-Therese Holzer, Nikolas Ruffer, Dominic Borie, Johann Seibel, Catherina Lueck, Dietlinnde Janson, Christine Wolschke, Francis Ayuk, Ina Kötter, Nicolaus Kröger
Division of Rheumatology and Inflammatory Rheumatic Diseases, Department Internal Medicine III, University Medical Center; Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, University Hospital UKE Hamburg; Institute for Transfusion medicine, University Medical Center Hamburg-Eppendorf, Germany; Kyverna Therapeutics, Emeryville, CA, USA
2 A RETROSPECTIVE STUDY ON DESENSITISATION TREATMENT FOR HLA-DONOR SPECIFIC ANTIBODIES IN EX-VIVO T CELL DEPLETED HAPLOIDENTICAL ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN SINGAPORE
Than Hein, Christopher Tham, Jeffrey Quek, Tertius Tuy, Francesca Lim, Yunxin Chen, Chieh Hwee Ang, Liang Piu Koh, William Hwang, Aloysius Ho, Yeh Ching Linn
Department of Haematology, Singapore General Hospital; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore
3 ADDITION OF BENDAMUSTINE TO POSTTRANSPLANT CYCLOPHOSPHAMIDE IN RELAPSED AND REFRACTORY MYELOID MALIGNANCIES: PRELIMINARY ANALYSIS OF SINGLE CENTER EXPERIENCE
Nikolai Tsvetkov, Elena Morozova, Yulia Vlasova, Anna Smirnova, Sergey Bondarenko, Ivan Moiseev, Alexander Kulagin
RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia
4 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULTS WITH MYELODYSPLASTIC SYNDROME AND MYELODYSPLASTIC/MYELOPROLIFERATIVE OVERLAP NEOPLASMS: RESULTS OF THE ARGENTINEAN GROUP OF BONE MARROW TRANSPLANTATION AND CELL THERAPY
Jorge Arbelbide, Mercedes Garcia, Mariano Berro, Maria Marta Rivas, Alicia Enrico, Vera Milovic, Martin Castro, Priscila Wernicke, Soledad Cruset, Oliva Gelo, Amalia Cerutti, Maximiliano Cattaneo, Gonzalo Bentolila, Ana Lisa Basquiera, Micaela Quarchioni
Hospital Privado de Córdoba, Córdoba; Hospital Universitario Austral, Pilar, Buenos Aires;  Hospital Italiano de La Plata, La Plata, Buenos Aires; Hospital Alemán, CABA, Buenos Aires; Sanatorio Anchorena, CABA, Buenos Aires; Sanatorio Sagrado Corazón, CABA, Buenos Aires; Hospital El Cruce, Florencio Varela, Buenos Aires; Instituto Alexander Fleming, CABA, Buenos Aires; CETRAMOR, Rosario, Santa Fe; Centro de Hematología y Trasplante de Rosario, Rosario, Santa Fe: FUNDALEU, CABA, Buenos Aires: Hospital Británico de Buenos Aires, CABA, Buenos Aires, Argentina
5 ALLOGENIC STEM CELL TRANSPLANT FOR FANCONI ANEMIA A SINGLE CENTER EXPERIENCE
Eman Khattab, Mayada Abu Shanap, Rawad Rihani, Dua’A Zandaki, Hasan Hashem
King Hussein Cancer Center, Amman, Jordan
6 ALLOPIPE: FROM GENOMIC DATA TO MINOR HISTOCOMPATIBILITY ANTIGENS
Adèle Dhuyser, Adele Dhuyser, Alice Aarnink, Pierre Delaugere, Pierre Laville, Laurent Mesnard, Hugues Richard
HLA and Histocompatibility Laboratory, CHRU de Nancy; Nephrologic Intensive Care Unit (SINRA), Hôpital Tenon, APHP, Paris; Sorbonne Université Maison des Modélisations Ingénieuries et Technologies (SUMMIT), La Sorbonne Université , Paris; Common and Rare Kidney Diseases (CoRaKiD), UMR 1155 CNRS , La Sorbonne Université, Paris, France
Genome Competence Center MF1, Robert Koch Institut, Berlin, Germany
7 ANTI T LYMPHOCYTE GLOBULINE FOR GRAFT VERUS HOST PREVENTION IN REDUCED INTENSITY CONDITIONING TRANSPLANTS
Margherita Ursi, Francesco Barbato, Francesco De Felice, Marcello Roberto, Mario Arpinati, Enrico Maffini, Sadia Falcioni, Barbara Sinigaglia, Elisa Dan, Elena Campanini, Luca Zazzeroni, Alessandra Fortuna, Francesca Bonifazi
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Italy
8 COMBINATION OF LOW DOSE ANTI-THYMOCYTE GLOBULIN (ATG) AND REDUCED DOSE POST TRANSPLANT CYCLOPHOSPHAMIDE (PTCY), FOR HAPLOIDENTICAL STEM CELL TRANSPLANT IN ACUTE LEUKEMIA : A SINGLE CENTER RETROSPECTIVE STUDY
Tan Sen Mui, Wong Tien Gen, Sharifah Shahnaz, Tee Chuan Ong
Hospital Ampang , Ampang, Malaysia
9 COMPARABLE EFFICACY OF FLUDARABINE/CYCLOPHOSPHAMIDE VS ATG/CYCLOPHOSPHAMIDE CONDITIONING REGIMEN FOR APLASTIC ANEMIA PATIENTS RECEIVING MATCHED-SIBLING DONOR TRANSPLANTS: INSIGHTS FROM A SINGLE-CENTER EXPERIENCE IN PAKISTAN
Waseem Ahmed, Shafaq Abdul Samad, Uzma Zaidi
National Institute of Blood Disease and Bone Marrow Transplantation, Karachi, Pakistan
10 CONDITIONING REGIMEN WITH TREOSULFAN  FOR RELAPSE OF HEMATOLOGICAL MALIGNANCY AFTER 2ND ALLOGENEIC TRANSPLANTATION – ONE CENTER EXPERIENCE
Alzbeta Zavrelova, Pavel Zak, Katerina Zibridova, Benjamin Visek, Jana Stevkova, Miriam Lanska, Jakub Radocha, Jan Milos Horacek, Eva Cermakova
University Hospital Hradec Kralove, Hradec Kralove, Czechia; 4th Department of Internal Medicine – Hematology, University Hospital and Charles University Faculty of Medicine, Hradec Kralove; Department of Medical Biophysics, University Hospital and Charles University Faculty of Medicine, Hradec Kralove, Czech Republic
11 CORRELATION OF DCK GENE MUTATIONS WITH TREATMENT OUTCOME IN CYTARABINE RECIPIENTS IN ACUTE MYELOID LEUKEMIA
Kandarpa Saikia, Jina Bhattacharyya, Tandralee Bhuyan
Department of Clinical Hematology, Gauhati Medical College & Hospital, Guwahati, Assam; Department of Bioengineering and Technology, Gauhati University, Guwahati, Assam, India
12 DIFFERENT CLEARANCE OF KIT MUTATION AND TRYPTASE LEVELS AFTER HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM
Christian Niederwieser, Anita Badbaran, Radwan Massoud, Nico Gagelmann, Ameya Kunte, Evgeny Klyuchnikov, Niloufar Seyedi, Silke Heidenreich, Ina Rudolph, Normann Steiner, Gaby Zeck, Catherina Lueck, Dietlinde Janson, Christine Wolschke, Francis Ayuk, Nicolaus Kröger
University Hospital UKE Hamburg, Germany
13 DOES IMMUNOHISTOCHEMICAL STAINING PREDICT MOBILIZATION SUCCESS IN MULTIPLE MYELOMA PATIENTS?
Fatma Keklik Karadağ, Murat Aysin, Nur Soyer, Ajda Güneş, Denis Bozer, Derya Demir, Aysenur Arslan, Fahri Sahin, Mahmut Töbü, Güray Saydam, Filiz Vural
Balıkesir University, Faculty of Medicine, Department of Public Health, Balıkesir; Ege University Medical School, Department of Hematology, Izmir, Turkey and University of Ulm, Institute of Transfusion Medicine, Ulm, Germany
14 DOES THE ADDITION OF BRENTUXIMAB VEDOTIN TO SALVAGE THERAPY BEFORE TRANSPLANTATION AFFECT TRANSPLANT SUCCESS IN HODGKIN LYMPHOMA PATIENTS ? SINGLE CENTRE, PRELIMINARY RESULTS
Taner Tan, Hakan Kalyon, Emre Osmanbasoglu, Sinem Civriz Bozdag, Ümit Üre, Olga Meltem Akay
Koç University Hospital, Turkey
15 EXPANSION OF PLASMABLASTS AT DAY 90 AFTER ALLOGENEIC STEM CELL TRANSPLANTATION PREDICTS CHRONIC GVHD
Julia Winkler1, Katharina Habenicht2, Simon Schäfer2, Ingrid Vasova1, Matthias Fante3, Andrea Schneider1, Michael Rehli3,4, Petra Hofmann3,4, Matthais Edinger3,4, Wolfgang Herr3, Andreas Mackensen1, Daniel Wolff3, Thomas H. Winkler2
1Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen; 2Department of Biology, Division of Genetics, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nuremberg; 3Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg; 4Leibniz Institute for Immunotherapy, Regensberg, Germany
16 FATAL ACUTE GRAFT-VERSUS-HOST DISEASE IN SEZARY SYNDROME TREATED WITH MOGAMULIZUMAB AND HEMATOPOIETIC CELL TRANSPLANTATION
Gentiana Elena Trotta, Giulia Ciangola, Ilaria Cerroni, Valeria Mezzanotte, Andrea Nunzi, Luca Savino, Gottardo De Angelis, Benedetta Mariotti, Fabrizio Bonanni, Elisa Meddi, Annagiulia Zizzari, Vito Mario Rapisarda, Ilaria Mangione, Antonio Burno, Maria Cantonetti, Adriano Venditti, Raffaella Cerretti
Unità Trapianto di Cellule Staminali Ematopoietiche, Dipartimento di Oncoematologia, Fondazione Policlinico di Tor Vergata, Rome; Ematologia and Unità Anatomia Patologica, Dipartimento di Biomedicina e Prevenzione Università degli Studi di Roma Tor Vergata, Rome, Italy
17 FAVOURABLE IMPACT OF POST-TRANSPLANT MINIMAL DISEASE NEGATIVITY ASSESSED BY FLOW CYTOMETRY ON SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Evgeny Klyuchnikov1, Anita Badbaran1, Tetiana Perekhrestenko2, Norman Steiner1, Radwan Massoud1, Petra Freiberger1, Christine Wolschke1, Francis Ayuk1, Ulrike Bacher3 and Nicolaus Kröger1
1Department for Stem Cell Transplantation, University Cancer Center Hamburg-Eppendorf, Germany; 2Shupyk National Healthcare University of Ukraine; 3Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Switzerland
18 GRANULOCYTE COLONY STIMULATING FACTOR DURING CYTAPHERESIS INCREASES THE HARVESTED STEM CELL NUMBER IN MULTIPLE MYELOMA PATIENTS
Stanislav Simeonov, Ivan Tonev, Milcho Mincheff
National Specialized Hospital for Active Treatment of Hematological Diseases, Bulgaria
19 INCIDENCE AND RISK FACTOR OF VENO-OCCLUSIVE DISEASE AND ENDOTHELIAL DYSFUNCTION EVENTS IN HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
Gonzalo Bentolila1, Mariano Berro2, Daiana Rodríguez3, Mercedes de Jesús Garcia4, Martin Castro5, Adriana Vitriu6, Patricio Duarte7, Amalia Cerutti8 , Juliana Martinez Rolon1, Ana Lisa Basquiera4
1Fundación contra la Leucemia (FUNDALEU), Ciudad Autónoma de Buenos Aires; 2Hospital Universitario Austral, (HUA) Pilar Prov. De Buenos Aires; 3Hospital Italiano de Buenos Aires (HIBA), Ciudad Autónoma de Buenos Aires; 4Hospital Privado de Córdoba, Córdoba, Argentina (HPC); 5Sanatorio Anchorena, Ciudad Autónoma de Buenos Aires; 6Instituto Alexander Fleming (IAF), Ciudad Autónoma de Buenos Aires;  7Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC); 8Sanatorio Británico, Rosario, Santa Fe, Argentina
20 LONG-TERM OUTCOME OF PATIENTS WITH GRAFT FAILURE AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. RESULTS OF A SINGLE CENTER ANALYSIS
Khalid Halahleh, Husam Abu-Jazar, Rozan B. Al Far, Mohamad Makoseh, Ahmad Abukhader, Alia Alqneibi, Waleed Dana, Maher Sughayer, Nazmi Kamal, Iyad Sultan
King Hussein Cancer Center, Amman, Jordan
21 LONG-TERM SURVIVAL ANALYSIS OF PRIMARY IMMUNODEFICIENCY DISORDERS, INSIGHTS FROM A LOW-MIDDLE INCOME COUNTRY.
Waseem Ahmed, Shafaq Abdul Samad, Zainab Ghias, Uzma Zaidi
National Institute of Blood Disease and Bone Marrow Transplantation, Karachi, Pakistan
22 MELPHALAN INDUCED INTESTINAL MUCOSITIS IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT: RAPID RESPONSE TO SHORT COURSE OF ORAL BUDESONIDE
Rammurti Kamble, Gloria Obi, Audrey Scholoff, Susan Jacob, Romelia May, Breanna Hinman, Geroge Carrum
Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX, USA
23 PRETRANSPLANT MYELOID AND IMMUNE SUPPRESSION (PMIS) FOR THALASSEMIA PATIENTS RECEIVING MATCHED RELATED DONOR ALLOGRAFT
Eman Khattab, Hasan Hashem, Mayada Abu-Shanap, Dua’A Zandaki, Rawad Rihani
King Hussein Cancer Center, Amman, Jordan
24 QUANTUM-FIRST: SAFETY BY TREATMENT PHASE AND BY AGE IN NEWLY DIAGNOSED PATIENTS WITH FMS-LIKE TYROSINE KINASE 3–INTERNAL TANDEM DUPLICATION  POSITIVE ACUTE MYELOID LEUKEMIA
Richard F Schlenk1, Harry P Erba2, Hervé Dombret3, Alexander E Perl4, Christoph Bürth5, Tsvetomir Mitov6, Li Liu7, Yasser Mostafa Kamel7, Karima Imadalou7, Youngsook Choi5, Mark J Levis8
1National Center of Tumor Diseases Trial Center, German Cancer Research Center and Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; 2Duke Cancer Institute, Durham, NC, USA; 3Saint Louis Hospital, University of Paris, Paris, France; 4Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA, USA; 5Daiichi Sankyo Germany, Munich Germany; 6Daiichi Sankyo UK, London, UK; 7Daiichi Sankyo, Basking Ridge, NJ, USA; 8Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD, USA
25 QUANTUM-FIRST TRIAL: FMS-LIKE TYROSINE KINASE 3-INTERNAL TANDEM DUPLICATION–SPECIFIC MEASURABLE RESIDUAL DISEASE CLEARANCE ASSESSED THROUGH INDUCTION AND CONSOLIDATION IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN NEWLY DIAGNOSED  FLT3-ITD+ AML PATIENTS
Alexander E. Perl1, Harry P. Erba2, Pau Montesinos3, Radovan Vrhovac4, Elżbieta Patkowska5, Hee-Je Kim6, Pavel Zak7, Po-Nan Wang8, Sebastian Heck9, Jaime E. Connolly Rohrbach10, Ken C.N. Chang10, Li Liu10, Yasser Mostafa Kamel10, Karima Imadalou10, Arnaud Lesegretain10, Jorge Cortes11, Mikkael A. Sekeres12, Hervé Dombret13, Sergio Amadori14, Jianxiang Wang15, Richard F. Schlenk16, Mark J. Levis17
1University of Pennsylvania, Philadelphia, USA; 2Duke Cancer Institute, Durham, NC, USA; 3La Fe University and Polytechnic Hospital, Valencia, Spain; 4University Hospital Centre Zagreb, Croatia; 5Hematology, IHIT Institute of Hematology and Blood Transfusion, Warsaw, Poland; 6Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, South Korea; 7University Hospital Hradec Kralove, Czechia; 8Chang Gung Medical Foundation, Linkou, Taiwan; 9Daiichi Sankyo Germany, Munich Germany; 10Daiichi Sankyo, Inc, Basking Ridge, NJ, USA; 11Georgia Cancer Center at Augusta University, GA, USA; 12Sylvester Cancer Center, University of Miami Health System, FL, USA; 13Saint Louis Hospital, University of Paris, France; 14Tor Vergata Polyclinic Hospital Rome, Italy; 15Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; 16Heidelberg University Hospital and German Cancer Research Center, Germany; 17Johns Hopkins University, Baltimore, MD, USA
26 SEQUENTIAL CONDITIONING WITH FLAMSA DOES NOT IMPROVE OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION IN CMML PATIENTS
Radwan Massoud, Evgeny Klyuchnikov, Normann Steiner, Gaby Zeck, Silke Heidenreich, Claudia Langebrake, Christian Niederwieser, Kristin Rathje, Nico Gagelmann, Dietlinde Janson, Christine Wolschke, Francis Ayuk, Nicolaus Kröger
University Hospital UKE Hamburg; Department of Stem Cell transplantation, University Medical Center Hamburg Eppendorf, Hamburg; Hospital Pharmacy, University Medical Center Hamburg Eppendorf, Hamburg, Germany
27 SUCCESSFUL TREATMENT OF THREE DIFFERENT CONGENITAL HEMATOLOGICAL DISEASES WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
Dilek Ece, Ayşe Sayılı, Hakan Sarbay, Zeynep Doğusan, Abdullah Avni Atay, Zeynep Ocak, Barış Malbora
Burhan Nalbantoglu Public Hospital Department of Pediatric Hematology, Oncology, North Cyprus; Bagcilar Education and Training Hospital Department of Pediatric Hematology, Oncology, Istanbul; Flow Cytometry and Cell Processing Unit, Pediatric Hematology and Oncology Unit and Pediatric Bone Marrow Transplantation Unit, Ecegen Molecular Genetics Laboratory, Yeniyuzyil University Gaziosmanpasa Hospital, Istanbul, Turkey
28 THE INCIDENCE AND IMPACT OF ACUTE KIDNEY INJURY IN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS
Beatrice Duarte, Fernando Duarte, Pastora Duarte
Federal University of Ceará (UFC), Brazil
29 THE RISK OF BK-HEMORRHAGIC CYSTITIS IN THE ERA OF POST-TRANSPLANTATION CYCLOPHOSPHAMIDE
Marco Mielcarek, Hu Xie, Hannah Imlay, Wendy Leisenring, Michael Boeckh
Fred Hutchinson Cancer Center; Clinical Research Division, Seattle, WA; University of Utah, Division of Infectious Diseases, Department of Internal Medicine, Salt Lake City, UT; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA
30 TO STUDY THE BREAKPOINT CLUSTER REGION-ABELSON GENE MUTATION AND THEIR RESISTANCE TO IMATINIB, A TYROSINE KINASE INHIBITOR IN CHRONIC MYELOID LEUKEMIA IN ASSAM, INDIA
Doly Barman, Kandarpa Kumar Saikia
Gauhati University, Guwahati, India